Aisling Capital Lowered Its Transenterix (TRXC) Stake by $446,467; Highlander Capital Management Has Trimmed Holding in Bristol Myers Squibb Co (BMY) by $698,450

May 11, 2018 - By Nellie Frank

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Logo

Highlander Capital Management Llc decreased its stake in Bristol Myers Squibb Co (BMY) by 67.86% based on its latest 2017Q4 regulatory filing with the SEC. Highlander Capital Management Llc sold 11,450 shares as the company’s stock rose 2.38% while stock markets declined. The institutional investor held 5,424 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $332,000, down from 16,874 at the end of the previous reported quarter. Highlander Capital Management Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $83.98B market cap company. The stock increased 0.41% or $0.21 during the last trading session, reaching $51.36. About 4.27M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since May 11, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Dennis Purcell decreased its stake in Transenterix Inc. (TRXC) by 4.32% based on its latest 2017Q4 regulatory filing with the SEC. Aisling Capital Llc sold 446,467 shares as the company’s stock declined 18.72% with the market. The hedge fund run by Dennis Purcell held 9.89M shares of the health care company at the end of 2017Q4, valued at $19.09 million, down from 10.34 million at the end of the previous reported quarter. Aisling Capital Llc who had been investing in Transenterix Inc. for a number of months, seems to be less bullish one the $422.12M market cap company. The stock increased 2.45% or $0.05 during the last trading session, reaching $2.09. About 1.38 million shares traded. TransEnterix, Inc. (NYSEMKT:TRXC) has risen 34.15% since May 11, 2017 and is uptrending. It has outperformed by 22.60% the S&P500.

Investors sentiment increased to 2.2 in 2017 Q4. Its up 1.29, from 0.91 in 2017Q3. It is positive, as 9 investors sold TRXC shares while 11 reduced holdings. 26 funds opened positions while 18 raised stakes. 50.72 million shares or 32.03% more from 38.42 million shares in 2017Q3 were reported. Hightower Advsr Ltd Liability Corporation owns 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 88,368 shares. Bowling Portfolio Ltd Llc has 20,000 shares. Stratos Wealth Prtnrs Ltd invested in 3,742 shares or 0% of the stock. Wells Fargo & Company Mn holds 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC) or 13,520 shares. Virtu Ltd Com reported 0.01% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Bank Of Ny Mellon stated it has 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Comerica Bank stated it has 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Annex Advisory Serv Ltd Liability holds 11,600 shares or 0% of its portfolio. Deutsche Bank Ag holds 1,347 shares. Lpl Limited Liability Corporation reported 0% stake. Stifel Fincl invested in 0% or 102,414 shares. Jfs Wealth Advsrs Ltd Limited Liability Company accumulated 500 shares. Focused Wealth Mgmt Inc invested in 1,000 shares. 1,000 are held by Cwm Ltd Com. Redmile Group Ltd Liability Company holds 0.42% in TransEnterix, Inc. (NYSEAMERICAN:TRXC) or 5.02 million shares.

Highlander Capital Management Llc, which manages about $131.70 million and $136.75 million US Long portfolio, upped its stake in General Electric Company (NYSE:GE) by 68,975 shares to 108,954 shares, valued at $1.90M in 2017Q4, according to the filing. It also increased its holding in Oracle Corporation (NYSE:ORCL) by 6,900 shares in the quarter, for a total of 17,687 shares, and has risen its stake in Cbs Corp (NYSE:CBS).

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It turned negative, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Amica Retiree Med Trust holds 0.46% or 9,944 shares in its portfolio. Gradient reported 0.03% in Bristol-Myers Squibb Company (NYSE:BMY). Penn Davis Mcfarland holds 135,332 shares. 1.51M were reported by State Of Tennessee Treasury Department. Evercore Wealth Management Lc reported 0.27% stake. First Merchants, Indiana-based fund reported 6,795 shares. 789 are owned by Earnest Ptnrs Ltd Company. Bath Savings Tru holds 17,762 shares or 0.27% of its portfolio. Kidder Stephen W has 0.15% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 6,600 shares. West Virginia-based Security National Tru has invested 1.34% in Bristol-Myers Squibb Company (NYSE:BMY). Old Second Bank & Trust Of Aurora invested 0.14% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Iberiabank Corp holds 23,686 shares. Financial Architects Inc reported 0.14% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Hbk Lp invested in 100,700 shares or 0.06% of the stock. City Holding reported 0.76% in Bristol-Myers Squibb Company (NYSE:BMY).

Since December 12, 2017, it had 2 insider purchases, and 1 insider sale for $163,963 activity. On Tuesday, December 12 Lynch Thomas J. Jr. sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) or 5,300 shares. Shares for $249,948 were bought by Paliwal Dinesh C.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>